Szívfibrotikus

Szívfibrotikus, also known as cardiac fibrosis, is a condition characterized by the excessive accumulation of fibrous tissue in the heart. This tissue replaces the normal cardiac muscle, leading to a stiffening and thickening of the heart. The primary cause of cardiac fibrosis is often heart disease, including coronary artery disease, hypertension, and valvular heart disease. Other contributing factors may include genetic predisposition, infections, and certain medications.

The condition can lead to a variety of symptoms, including shortness of breath, fatigue, and chest pain. In severe cases, it can progress to heart failure, where the heart is unable to pump blood effectively. The diagnosis of cardiac fibrosis typically involves imaging techniques such as echocardiography, cardiac MRI, or cardiac CT scan, which can visualize the extent of fibrosis.

Treatment for cardiac fibrosis focuses on managing the underlying cause and improving heart function. This may include lifestyle modifications such as a heart-healthy diet and regular exercise, as well as medications to control blood pressure, cholesterol levels, and other risk factors. In some cases, surgical interventions or device-based therapies may be necessary to support heart function.

Prognosis varies depending on the severity of the condition and the effectiveness of treatment. With proper management, many individuals with cardiac fibrosis can lead active lives. However, the condition is progressive, and long-term monitoring and management are essential to prevent complications.